Vered Stearns, MD | Authors

Articles

CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?

May 15, 2018

Here, we review the current use of and potential next directions for CDK4/6 inhibitors in the treatment of patients with HR-positive breast cancer.

Controversies in Treating Early HR-Positive Breast Cancer

December 14, 2017

This video reviews controversies in the treatment of early-stage hormone receptor (HR)-positive breast cancer.

Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions

November 16, 2015

In this review, we will discuss multidisciplinary considerations in treating patients with neoadjuvant therapy and highlight areas of controversy and ongoing research.

Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer

June 15, 2013

The goals of care for patients with hormone receptor (HR)-positive advanced breast cancer include prolongation of disease-free and overall survival, amelioration of symptoms, and improvement in quality of life.